Screening
Type 2 diabetes screening
Risk-based screening intervals using validated tools.
Last reviewed 2026-01-04|endocrine | metabolic | screening | prevention
Who to screen: asymptomatic adults with high or very high risk based on validated tools (FINDRISC or CANRISK). Routine screening is not recommended for low or moderate risk.
Test and interval: A1C is preferred; fasting plasma glucose or OGTT are acceptable. Screen high-risk adults every 3-5 years and very high-risk adults annually.
Follow-up: confirm abnormal results per local standards and begin risk factor management. Document risk score, test used, and recall interval.